Mathilde Cancel
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 26, 2026
Systemic management of spinal metastases: current strategies and future directions.
Journal: Neuro-Chirurgie
Published: April 02, 2026
Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2025
From One Cancer to Two: [¹⁸F]FES PET/CT Redirected Diagnosis and Therapy in a Metastatic Breast Cancer Patient.
Journal: Clinical nuclear medicine
Published: November 07, 2025
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 12, 2025
Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: October 09, 2025
Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE study.
Journal: BMJ open
Published: September 04, 2025
Guidelines to optimise ePROs monitoring for older patients under systemic cancer treatment from the French Society of Geriatric oncology (SoFOG) based on a delphi consensus.
Journal: Journal of geriatric oncology
Published: May 20, 2025
Investigation of the heterogeneity of cancer cells using single cell Ca2+ profiling.
Journal: Cell communication and signaling : CCS
Published: April 30, 2025
Oncologists and hematologists' perspective on advance directives. A French national survey
Journal: Bulletin du cancer
Published: January 31, 2025
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2024
Treatment breaks in an oncology unit.
Journal: BMJ supportive & palliative care
Published: May 13, 2024
Last Updated: 09/26/2026